Glasgow, United Kingdom, 3rd July, 2014 – Qnostics Ltd. announced today that it has received CE Marked status for its new CMV molecular controls. These products are a welcome addition to the existing range of respiratory and transplant molecular controls.

“The launch of the CMV CE Marked molecular controls is a major achievement for Qnostics. This is the first CE Marked control of its kind to be launched in Europe and is a key milestone in reinforcing Qnostics’ reputation as a supplier of high quality molecular controls.” said Gordon Powell, CEO.

“The CE Marked CMV controls are yet another Qnostics’ product that will facilitate our customers in maintaining their ISO:15189 status, which ensures the highest quality standards within their testing laboratory.”

Qnostics’ molecular controls are provided in three formats which provides laboratories with the ability to control all aspects of their assay’s performance. The controls are available through our network of international distributors. For more information please contact Qnostic’s customer services at +44 141 946 4207 or, US enquiries should be directed to our US office at (888) 976-6784.


About Qnostics Ltd.

Qnostics is a manufacturer of a variety of own-label and custom manufactured molecular controls.

Qnostics specialises in the development, manufacture and distribution of Molecular Controls for use within the standard procedures of today’s molecular laboratory. In addition to product supply, Qnostics Ltd has, since 2003, been a service provider to other IVD, Molecular Diagnostics, Pharmaceutical and CRO organisations. Primary focus for the company is on infectious diseases, including the availability of hundreds of molecular characterised viral, bacterial and fungal targets.

The main manufacturing facility in the United Kingdom is supported by commercial offices in the United Kingdom and United States. These two offices further support a network of international distribution partners. For more information, visit our new website at